Tumor cells with low expression of PLCγ1 show stronger hypoxia adaptation and higher proliferation activity, suggesting that elevated PLCγ1 expression may serve as a biomarker for poor NSCLC prognosis [56]. This evidence concerns the gene PLCG1 and non-small cell lung carcinoma.